MedPath

The effect of Gabapentin (Neurentin) and Pregabalin (Lyrica) in pain reduction after photorefractive keratectomy (PRK)

Phase 2
Conditions
Refractive errors.
Disorders of refraction and accommodation
Registration Number
IRCT1138901211180N12
Lead Sponsor
Ophthalmic Research Center
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
50
Inclusion Criteria

patients who are candidate for PRK, age between 18 to 70. Exclusion criteria: using any systemic analgesic drugs, drug intolerance, need of systemic or topical administration of NSAIDs or eye drops for allergy and glaucoma, dry eyes, pregnancy, breast feeding.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pain. Timepoint: 3rd day. Method of measurement: visual analog scale (VAS ).
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath